Terms: = Head and neck cancer AND NBN, AT-V2, 4683, ENSG00000104320, ATV, FLJ10155, NBS, AT-V1, MGC87362, NBS1
93 results:
1. Atorvastatin-loaded cubosome: a repurposed targeted delivery systems for enhanced targeting against breast cancer.
El-Marakby EM; Fayez H; Motaleb MA; Mansour M
Pharm Dev Technol; 2024 Mar; 29(3):236-247. PubMed ID: 38451055
[TBL] [Abstract] [Full Text] [Related]
2. Comparisons of Non-Oral Immune-Related Adverse Events Among Patients With cancer With Different Oral Toxicity Profiles.
Xu Y; Wen N; Haddad RI; Sonis ST; Villa A
Oncologist; 2024 Mar; 29(3):e382-e391. PubMed ID: 37874927
[TBL] [Abstract] [Full Text] [Related]
3. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Impact of Proton Beam Therapy for Postoperative Lymph Node Oligorecurrence of Esophageal cancer.
Hiroshima Y; Ishikawa H; Sumiya T; Murakami M; Nakamura M; Ishida T; Ogawa K; Hisakura K; Mizumoto M; Oda T; Okumura T; Sakurai H
In Vivo; 2023; 37(3):1253-1259. PubMed ID: 37103111
[TBL] [Abstract] [Full Text] [Related]
5. XRCC3 and nbs1 gene polymorphisms modulate the risk of pre-oral cancer and oral cancer in the North Indian population.
Nigam K; Gupta S; Singh N; Yadav SK; Sanyal S
J Cancer Res Ther; 2023; 19(2):304-311. PubMed ID: 37006067
[TBL] [Abstract] [Full Text] [Related]
6. Adult Thyroid Outcomes of Congenital Hypothyroidism.
Sugisawa C; Narumi S; Tanase-Nakao K; Hoshiyama A; Suzuki N; Ohye H; Fukushita M; Matsumoto M; Yoshihara A; Watanabe N; Sugino K; Hishinuma A; Noh JY; Katoh R; Taniyama M; Ito K
Thyroid; 2023 May; 33(5):556-565. PubMed ID: 36792927
[No Abstract] [Full Text] [Related]
7. MYH9 Facilitates Cell Invasion and Radioresistance in head and neck cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway.
You GR; Chang JT; Li YL; Huang CW; Tsai YL; Fan KH; Kang CJ; Huang SF; Chang PH; Cheng AJ
Cells; 2022 Sep; 11(18):. PubMed ID: 36139430
[TBL] [Abstract] [Full Text] [Related]
8. HPV16 Induces Formation of Virus-p62-PML Hybrid Bodies to Enable Infection.
Schweiger L; Lelieveld-Fast LA; Mikuličić S; Strunk J; Freitag K; Tenzer S; Clement AM; Florin L
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891458
[TBL] [Abstract] [Full Text] [Related]
9. Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy.
Schnöller LE; Albrecht V; Brix N; Nieto AE; Fleischmann DF; Niyazi M; Hess J; Belka C; Unger K; Lauber K; Orth M
Radiat Oncol; 2022 Apr; 17(1):79. PubMed ID: 35440003
[TBL] [Abstract] [Full Text] [Related]
10. Expression of DNA-damage response and repair genes after exposure to DNA-damaging agents in isogenic head and neck cells with altered radiosensitivity.
Todorovic V; Groselj B; Cemazar M; Prevc A; Zakelj MN; Strojan P; Sersa G
Radiol Oncol; 2022 Apr; 56(2):173-184. PubMed ID: 35390246
[TBL] [Abstract] [Full Text] [Related]
11. PARP5B is required for nonhomologous end joining during tumorigenesis in vivo.
Wu J; Crowe DL
Mol Carcinog; 2022 Jan; 61(1):85-98. PubMed ID: 34710250
[TBL] [Abstract] [Full Text] [Related]
12. MRE11 promotes oral cancer progression through RUNX2/CXCR4/AKT/FOXA2 signaling in a nuclease-independent manner.
Wang YY; Chen YK; Lo S; Chi TC; Chen YH; Hu SC; Chen YW; Jiang SS; Tsai FY; Liu W; Li RN; Hsieh YC; Huang CJ; Yuan SF
Oncogene; 2021 May; 40(20):3510-3532. PubMed ID: 33927349
[TBL] [Abstract] [Full Text] [Related]
13. Oral side effects of immune checkpoint inhibitor therapy (ICIT): An analysis of 4683 patients receiving ICIT for malignancies at Massachusetts General Hospital, Brigham & Women's Hospital, and the Dana-Farber cancer Institute, 2011 to 2019.
Xu Y; Wen N; Sonis ST; Villa A
Cancer; 2021 Jun; 127(11):1796-1804. PubMed ID: 33595843
[TBL] [Abstract] [Full Text] [Related]
14. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid cancer: The Influence of DNA Repair Genes Variants.
S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
[TBL] [Abstract] [Full Text] [Related]
15. LncRNA SLC26A4-AS1 suppresses the MRN complex-mediated DNA repair signaling and thyroid cancer metastasis by destabilizing DDX5.
Yuan J; Song Y; Pan W; Li Y; Xu Y; Xie M; Shen Y; Zhang N; Liu J; Hua H; Wang B; An C; Yang M
Oncogene; 2020 Oct; 39(43):6664-6676. PubMed ID: 32939012
[TBL] [Abstract] [Full Text] [Related]
16. Influence of Sevoflurane-Based Anesthesia versus Total Intravenous Anesthesia on Intraoperative Neuromonitoring during Thyroidectomy.
Li X; Zhang B; Yu L; Yang J; Tan H
Otolaryngol Head Neck Surg; 2020 Jun; 162(6):853-859. PubMed ID: 32178568
[TBL] [Abstract] [Full Text] [Related]
17. Genetic Variations of
Psoma E; Koliou GA; Dimitrakopoulos FI; Papadopoulou K; Rontogianni D; Bobos M; Visvikis A; Kosmidis PA; Fountzilas G; Constantinidis J; Kalogera-Fountzila A
Anticancer Res; 2020 Feb; 40(2):677-688. PubMed ID: 32014908
[TBL] [Abstract] [Full Text] [Related]
18. PD-L1 and MRN synergy in platinum-based chemoresistance of head and neck squamous cell carcinoma.
Shen B; Huang D; Ramsey AJ; Ig-Izevbekhai K; Zhang K; Lajud SA; O'Malley BW; Li D
Br J Cancer; 2020 Mar; 122(5):640-647. PubMed ID: 31853007
[TBL] [Abstract] [Full Text] [Related]
19. Treatment for benign thyroid nodules with a combination of natural extracts.
Stancioiu F; Mihai D; Papadakis GZ; Tsatsakis A; Spandidos DA; Badiu C
Mol Med Rep; 2019 Sep; 20(3):2332-2338. PubMed ID: 31322200
[TBL] [Abstract] [Full Text] [Related]
20. Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair.
Li D; Ye L; Lei Y; Wan J; Chen H
BMB Rep; 2019 Mar; 52(3):208-213. PubMed ID: 30638177
[TBL] [Abstract] [Full Text] [Related]
[Next]
